The nation's #1 heart program by U.S. News & World Report for 13 years in a row!
Site Search
Advanced Search

Future Treatments and Research


The George M. and Linda H. Kaufman Center for Heart Failure has been active and successful making many significant achievements including:

  • Innovative new surgical and medical therapies for heart failure
  • The Cardiac Transplant Program continues to be recognized as the one of the top three programs in the United States in terms of both volume and outcomes.
  • Creation of a heart failure patient management program
  • An extraordinary number of scientific publications International and national presentations at all major scientific assemblies
  • Kaufman Center personnel are in leadership positions in the most prominent medical, surgical and transplant professional societies

The Kaufman Center for Heart Failure continues to attract new patient referrals seeking precise diagnosis and cutting edge medical or surgical therapies for heart failure.

Clinical Research

The Kaufman Center for Heart Failure is involved in a wide spectrum of clinical research activities that focus on the challenges presented by both patients with heart failure and those who have undergone heart transplantation. These projects range from single center research efforts to participation in multi center clinical trials.

Basic Research

The Kaufman Center for Heart Failure supports a variety of innovative studies to determine the cause and effects of heart failure and point us in the direction of future therapeutic approaches.

  • Dr. Christine Moravec, Kaufman Center for Heart Failure, Department of Cardiovascular Medicine: Investigation of sub-cellular events associated with end-stage heart failure and the potential for recovery. Also interested in Alterations in excitation-contraction coupling in the failing heart and the possibility of reversing changes by mechanical unloading.
  • Dr. David VanWagoner, Department of Cardiovascular Medicine: Electrophysiology studies to determine the sub-cellular basis for atrial fibrillation and for the increased arrhythmia associated with heart failure. See Department of Molecular Cardiology
  • Dr. Kiyotaka Fukamachi, The collaboration of surgeons in the Kaufman Center for Heart Failure and Dr. Kiyo Fukamchi in the Department of Biomedical Engineering has produced innovative new blood pump technology. The National Institutes of Health has just awarded a two multi-million dollar grants titled "PediPump," A Versatile, Implantable Pediatric Ventricular Assist Device” and “Development and Clinical Testing of CorAide RVAD/BVAD” to Dr. Fukamachi. See Department of Biomedical Engineering

     

©Cleveland Clinic Foundation, revised 7/04

 
Contact Us     About This Site     Site Map     Privacy Statement      Disclaimer     www.clevelandclinic.org

This information is provided for education purposes only and is not intended to replace the medical advice of your doctor or health care provider. While we strive to keep our website current, medical practices sometimes change quickly. Please consult your health care provider for advice about a specific medical condition or contact the Cleveland Clinic if you would like an appointment.